Trinity Biotech (NASDAQ:TRIB – Get Rating) issued its quarterly earnings results on Monday. The company reported ($0.06) EPS for the quarter, missing the Zacks’ consensus estimate of $0.07 by ($0.13), Fidelity Earnings reports. Trinity Biotech had a negative return on equity of 3,160.63% and a negative net margin of 7.42%. Shares of TRIB opened at […]
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Rating) in a report issued on Sunday morning. The firm issued a buy rating on the stock. Separately, TheStreet downgraded Trinity Biotech from a c- rating to a d- rating in a research note on Monday, December 20th. TRIB stock opened at $1.02 on […]